Coming Soon Announcement
We are excited to announce our new CU Medicine brand and website!
The website you are on currently, will redirect to the new CU Medicine website starting Tuesday, January 19, 2020.
Our new website is designed to be the central hub of resources where visitors can find a wealth of information about CU Medicine providers, clinic locations and much more.
Marco Del Chiaro, MD
Professor, Surgery-Surgical Oncology
Division Chief, Surgical Oncology
Clinical Director, Hepato-Pancreato-Biliary Program
English, Italian, Swedish, French
Conditions & Treatments
Surgery - Complex General Surgical Oncology, Board Certification
Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
- Digestive System
Pancreas Transplant Surgery
Clinical Interest for Patients
Pancreas, Bile duct, Liver, Stomach, Adrenal, Sarcoma, and Cancer Surgery
Dr. Marco Del Chiaro is a surgical oncologist with 15 years of experience in the treatment of pancreatic diseases. He is internationally recognized as a leader in the surgical treatment of borderline resectable\locally advanced pancreatic cancer, as well as in the diagnosis and treatment of pancreas lesions. Dr. Del Chiaro's unique approach, combined with multimodal chemoradiotherapy, allows more surgical options for locally advanced pancreatic cancer patients. He is active in academic research, with more than 130 peer reviewed papers, and is a member of several scientific journals’ editorial boards. Dr. Del Chiaro's mission is to improve pancreatic cancer survival through both prevention and aggressive treatment of the advanced tumors and to create a multimodal personalized treatment for each patient.